tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yigal Nochomovitz, 98 are a HOLD (18.22%), 423 are a BUY (78.62%), 17 are a SELL (3.16%).
Analyst Yigal Nochomovitz, currently employed at CITI, carries an average stock price target met ratio of 42.79% that have a potential upside of 48.58% achieved within 179 days.
Yigal Nochomovitz’s has documented 1,076 price targets and ratings displayed on 60 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARVN, Arvinas at 19-Mar-2026.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 12/24/2015. The price target of $19 was fulfilled within 4 days with a profit of $16.57 (46.58%) receiving and performance score of 116.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Aug-2022
$13
3 years 6 months 20 days ago
(29-Aug-2022)
1/5 (20%)
$4.7 (56.63%)
176
Hold Since 24-Aug-2022
3 years 6 months 25 days ago
(24-Aug-2022)
0/1 (0%)
$6.53 (25.64%)
Hold Since 24-Aug-2022
$20
3 years 6 months 25 days ago
(24-Aug-2022)
0/4 (0%)
$14.21 (245.42%)
Buy Since 19-Mar-2014
$15.25
$27
3 years 6 months 26 days ago
(23-Aug-2022)
7/11 (63.64%)
$0.09 (0.59%)
149
Hold Since 23-Aug-2022
$14
3 years 6 months 26 days ago
(23-Aug-2022)
6/14 (42.86%)
$6.36 (83.25%)
228
Which stock is Yigal Nochomovitz is most bullish on?
Which stock is Yigal Nochomovitz is most reserved on?
What Year was the first public recommendation made by Yigal Nochomovitz?
